{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/end-of-life-care-in-children/background-information/prevalence/","result":{"pageContext":{"chapter":{"id":"b2be5c01-c4dc-5d84-b97a-9c02627704df","slug":"prevalence","fullItemName":"Prevalence","depth":2,"htmlHeader":"<!-- begin field dc031d2c-5063-4be5-83a7-aaa400ca152c --><h2>How common is it?</h2><!-- end field dc031d2c-5063-4be5-83a7-aaa400ca152c -->","summary":"","htmlStringContent":"<!-- begin item 9313fa87-a26f-4a5b-a12c-aaa400ca14dc --><!-- begin field c3e0ce46-23a5-4284-bbdf-aaa400ca152c --><ul><li>The prevalence of life-limiting conditions in children in England is both rising and higher than previously estimated and is more than double previous prevalence estimates [<a class=\"bibliography-reference internal-reference\" href=\"/topics/end-of-life-care-in-children/references/\">Fraser, 2015</a>].</li><li>It is estimated that there are around 49,000 children living with life-limiting conditions in the UK [<a class=\"bibliography-reference internal-reference\" href=\"/topics/end-of-life-care-in-children/references/\">Fraser, 2011</a>].  </li><li>Overall prevalence in people aged 0–19 years has increased from 25 per 10,000 in 2000/01 to 32 per 10,000 population in 2009/10, with prevalence highest in children aged under 1 year (126 per 10,000) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/end-of-life-care-in-children/references/\">Fraser, 2011</a>].  <ul><li>Prevalence has increased in all age groups but is most marked in those aged 16-19 years where there was a 44.8% increase over the 10 years. Prevalence increased by:<ul><li>37.9% in children aged 11–15 years.  </li><li>31.9% in children aged 6–10 years.</li><li>17.1% in children aged 1–5 years.</li><li>7·7% in children aged under 1 year. </li></ul></li><li>The increased prevalence in males (35.2%, 95% CI 34.7–35.7) is significantly higher than in females (29.2%, 95% CI 28.8–29.6).</li><li>Prevalence also varies with:<ul><li>Ethnicity — the highest prevalence is in people of South Asian origin (47.6 per 10,000, 95% CI 46.8 to 48.4), the Black population (41.5 per 10,000, 95% CI 39.5 to 43.5) and the Chinese and other population (30.7 per 10,000, 95% CI 29.4 to 32.0). These were significantly higher compared to the White population (27.0 per 10,000, 95% CI 26.7, 27.3).</li><li>Deprivation — the prevalence in each deprivation category over time shows an inverse J-shaped relationship with deprivation, with the highest prevalence in the most deprived category (category 1) and the lowest in the second most affluent group (category 4).</li><li>Geographical location — the North East, North West, West Midlands and London have a higher prevalence than the South West, Yorkshire and Humber and the East Midlands.</li></ul></li></ul></li><li>In England in 2017, there were around 3,000 child deaths due to medical conditions, of which 2,351 of these were due to a known life-limiting condition or a neonatal death [<a class=\"bibliography-reference internal-reference\" href=\"/topics/end-of-life-care-in-children/references/\">TSL, 2018</a>].</li></ul><!-- end field c3e0ce46-23a5-4284-bbdf-aaa400ca152c --><!-- end item 9313fa87-a26f-4a5b-a12c-aaa400ca14dc -->","topic":{"id":"9d93b3d3-3921-5862-b882-84c332dd8587","topicId":"1308e844-b1fc-40fe-8ebe-aa0600cc26ef","topicName":"End of life care in children","slug":"end-of-life-care-in-children","lastRevised":"Last revised August 2020","chapters":[{"id":"93913b2d-f47a-535d-b737-113d5a78a6e3","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"fcacb9ce-cec0-5815-9ffd-1bb79cacc366","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"7cef7a41-d21b-5f3c-9614-eb44180fe49b","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"7ceef71f-f345-5f65-8493-cf1407d8769a","slug":"changes","fullItemName":"Changes"},{"id":"3af00c0d-8fd5-5729-adf1-ab3dbfa2dee8","slug":"update","fullItemName":"Update"}]},{"id":"cb43ea50-8f55-5fe4-85d9-736bbcd4f855","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"51934eaf-e646-5cff-bd54-25d24d38b32b","slug":"goals","fullItemName":"Goals"},{"id":"2e34ce69-9de3-5697-a3db-8728de4d746b","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"72063db0-11f3-501a-91e6-84b237a7abc0","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"1aa7fb6c-342a-53de-ad67-400283e4f373","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"b453baae-c356-56ec-8281-10a108e865b3","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"2e208ab8-ac74-58c5-8500-3d57b84c7807","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"8132f93f-aa88-52d8-a4b5-c003936f3ee3","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"25282d21-6709-543d-a255-17240184a0d5","slug":"definition","fullItemName":"Definition"},{"id":"b2be5c01-c4dc-5d84-b97a-9c02627704df","slug":"prevalence","fullItemName":"Prevalence"}]},{"id":"ba7f5735-b22c-55c0-8419-f906c54df7b1","fullItemName":"Management","slug":"management","subChapters":[{"id":"04dd3782-f7d8-537c-a473-46e122175b13","slug":"management","fullItemName":"Scenario: Management"},{"id":"4640ef7c-26f1-5aef-b152-533f290f799a","slug":"managing-specific-care-issues","fullItemName":"Scenario: Managing specific care issues"}]},{"id":"7d89e3dd-c518-5b9d-9a1b-2e3593a77377","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"85cab945-f36e-59e3-bf62-88fe17b9c3fc","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"1ec279b1-c01c-580a-863a-bb817af91cf9","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"a35b823e-1965-5360-8d22-1774550d11a0","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"7ed02599-c40d-528e-a058-927488420ebe","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"449cacf7-647e-5b30-a5d5-384eaeb8d8ff","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"63e76423-ef72-5f3f-afbc-776c9cfa7276","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"413a52fc-b56a-5022-84a0-26df03c1dfb0","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"8132f93f-aa88-52d8-a4b5-c003936f3ee3","slug":"background-information","fullItemName":"Background information"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}